Dr. Faulhaber is Professor of Radiology at Case Western Reserve University and Director of Clinical PET at University Case Medical Center. He was steward of the transition of PET as a research tool to a clinical modality, and finally the transition to PET/CT. His clinical interests include all aspects of PET imaging in oncology, neurology and cardiology.
Dr. Faulhaber is particularly interested patient outcomes based on PET imaging. He has numerous research collaborations with clinical and basic research colleagues in ovarian, prostate and breast cancer, for example. Dr. Faulhaber is involved in the implementation of the new modality PET/MRI at University Hospitals Case Medical Center. He is part of a recent State of Ohio Third Frontier Award in PET/MRI applications in breast cancer. Dr. Faulhaber now is leading the initial clinical testing of a new PET detector solution from Philips Healthcare.
- Positron emission tomography (PET)
- PET imaging in oncology, neurology and cardiology
- Diagnostic radiology
- Nuclear medicine
Partovi S, Kohan A, Gaeta C, et al. Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction. American Journal of Nuclear Medicine and Molecular Imaging. 2013;3(3):291-299.
Kohan, A.A., Kolthammer, J.A., Vercher-Conejero, J.L. et al. N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: Initial experience. Eur Radiol (2013) 23: 3161.
Kershah, S., Partovi, S., Traughber, B.J. et al. Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population. Mol Imaging Biol (2013) 15: 776.